Ieq Capital LLC Invests $1.13 Million in Alignment Healthcare, Inc. $ALHC

Ieq Capital LLC bought a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) in the 2nd quarter, HoldingsChannel reports. The institutional investor bought 47,425 shares of the company’s stock, valued at approximately $1,129,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Summit Securities Group LLC bought a new position in Alignment Healthcare in the 4th quarter valued at $26,000. Versant Capital Management Inc increased its position in shares of Alignment Healthcare by 463.3% during the 2nd quarter. Versant Capital Management Inc now owns 1,380 shares of the company’s stock valued at $33,000 after purchasing an additional 1,135 shares during the last quarter. Parallel Advisors LLC raised its stake in shares of Alignment Healthcare by 87.7% during the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after purchasing an additional 773 shares during the period. Larson Financial Group LLC purchased a new position in shares of Alignment Healthcare in the 3rd quarter worth about $33,000. Finally, Signature Equity Partners LLC purchased a new position in shares of Alignment Healthcare in the 1st quarter worth about $46,000. 86.19% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Alignment Healthcare news, CEO John E. Kao sold 298,000 shares of the firm’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $13.88, for a total value of $4,136,240.00. Following the completion of the transaction, the chief executive officer directly owned 790,766 shares of the company’s stock, valued at $10,975,832.08. This trade represents a 27.37% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Hyong Kim sold 35,951 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $19.86, for a total transaction of $713,986.86. Following the transaction, the insider owned 331,750 shares of the company’s stock, valued at $6,588,555. This trade represents a 9.78% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 1,009,951 shares of company stock worth $18,597,287. Company insiders own 5.20% of the company’s stock.

Alignment Healthcare News Summary

Here are the key news stories impacting Alignment Healthcare this week:

• Neutral Sentiment: An AAII report discussed why Alignment Healthcare stock had risen, but the available headline provides no specific new fundamental catalyst, such as improved earnings guidance or a business announcement. Why Alignment Healthcare Stock Is Up
• Neutral Sentiment: Reported August short-interest data showed zero shares and a zero-day days-to-cover ratio, an internally inconsistent result that is unlikely to provide a meaningful signal for ALHC investors. Alignment Healthcare Short Interest Report
• Negative Sentiment: Kaplan Fox announced multiple investigations into Alignment Healthcare, its officers and directors, and potential violations of federal securities laws. The firm is seeking investors who suffered losses or have relevant information, raising the possibility of future shareholder claims. These are investigations and do not establish wrongdoing. Kaplan Fox Investigation
• Negative Sentiment: Lowey Dannenberg separately said it is investigating potential federal securities-law violations involving ALHC. The second law-firm inquiry reinforces near-term litigation uncertainty and could weigh on investor sentiment. Lowey Dannenberg Investigation
• Negative Sentiment: Kaplan Fox also urged Alignment Healthcare investors to contact the firm regarding a possible securities claim, repeating the investigation-related overhang across several releases. Kaplan Fox Possible Securities Claim

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Raymond James Financial lowered shares of Alignment Healthcare from a “strong-buy” rating to an “outperform” rating and reduced their price target for the company from $22.00 to $19.00 in a research report on Monday, August 3rd. KeyCorp reiterated an “overweight” rating on shares of Alignment Healthcare in a research note on Wednesday, June 10th. Barclays reduced their target price on shares of Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. UBS Group restated a “neutral” rating on shares of Alignment Healthcare in a research note on Wednesday, July 8th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Alignment Healthcare in a report on Tuesday, August 4th. Seven investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Alignment Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $23.60.

Alignment Healthcare Stock Up 2.3%

ALHC stock opened at $13.90 on Thursday. The stock has a 50-day simple moving average of $18.42 and a two-hundred day simple moving average of $18.63. Alignment Healthcare, Inc. has a twelve month low of $12.70 and a twelve month high of $25.12. The firm has a market capitalization of $2.88 billion, a PE ratio of 73.16 and a beta of 1.10. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 1.22.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, July 30th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.13 by $0.04. Alignment Healthcare had a net margin of 0.89% and a return on equity of 20.02%. The firm had revenue of $1.34 billion for the quarter, compared to the consensus estimate of $1.31 billion. During the same period in the prior year, the firm posted $0.07 earnings per share. The company’s revenue for the quarter was up 31.6% on a year-over-year basis. On average, equities analysts predict that Alignment Healthcare, Inc. will post 0.17 EPS for the current fiscal year.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.